Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis

Author： Shaw T. Nixon J.S. Bottomley K.M.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.7, 2000-07, pp. : 1469-1478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New prospects for the treatment of rheumatoid arthritis

By Choy E.H.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. : 1087-1097

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-03 ,pp. : 760-773

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: New Hope for Rheumatoid Arthritis?

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 803-820

Bentham Science Publishers

Access to resources Recommend Favorite

TNF- inhibitors and rheumatoid arthritis

By Shire M.G. Muller G.W.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 531-544

Informa Healthcare

Access to resources Recommend Favorite

Etoricoxib: A Review of its Use in the Symptomatic Treatment of Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis and Acute Gouty Arthritis

By Croom Katherine F. Siddiqui M. Asif A.

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1513-1532

Adis International

Access to resources Recommend Favorite